(Q95817349)

English

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan

scientific article published in July 2017

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

title

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

1 reference

Shunji Mugikura

1

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

Miki Fujimura

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

Shoki Takahashi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

Kei Takase

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

publication date

1 July 2017

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

volume

284

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

page(s)

301-303

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 May 2020

Identifiers

DOI

10.1148/RADIOL.2017170252

1 reference

stated in

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

Europe PubMed Central

PubMed ID

28628405

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28628405%20AND%20SRC:MED&resulttype=core&format=json

(Q95817349)

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)